Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2013-04-08

Clinical Trial Update: Treatment of Urinary Stress Incontinence During or Following Correction of Pelvic Organ Prolapse [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating treatment of urinary stress incontinence during or after correction of pelvic organ prolapse has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Magna Graecia | Conditions: Pelvic Organ Prolapse | Phase 4 | Status: WITHDRAWN